# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001999371-25-005478
Filing Date
2025-05-06
Accepted
2025-05-06 09:00:14
Documents
7
Period of Report
2025-06-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE PROXY STATEMENT | centessa_proxy-2025.htm | DEF 14A | 1833651
2 | GRAPHIC | centessa_proxy-2025img001.gif | GRAPHIC | 102431
3 | GRAPHIC | centessa_proxy-2025img002.gif | GRAPHIC | 508933
4 | GRAPHIC | centessa_proxy-2025img003.gif | GRAPHIC | 88932
5 | GRAPHIC | centessa_proxy-2025img004.gif | GRAPHIC | 77229
6 | GRAPHIC | proxy-1.jpg | GRAPHIC | 426229
7 | GRAPHIC | proxy-2.jpg | GRAPHIC | 359576
| Complete submission text file | 0001999371-25-005478.txt |  | 3988571

Mailing Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT
Business Address 3RD FLOOR 1 ASHLEY ROAD ALTRINCHAM, CHESHIRE X0 WA14 2DT 44 7391 789784
Centessa Pharmaceuticals plc (Filer) CIK: 0001847903 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40445 | Film No.: 25915570
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)